The effects of resveratrol and tannic acid on apoptosis in colon adenocarcinoma cell line

Saudi Medical Journal

Volumn 30, Issue 2, 2009, Pages 191-195

  Cosan, Didem ^a   Soyocak, Ahu ^a   Basaran, Ayse ^a   Degirmenci, Irfan ^a   Gunes, Hasan V ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR; FAS ASSOCIATED DEATH DOMAIN PROTEIN; PROTEIN BAK; PROTEIN BCL 2; RESVERATROL; TANNIN;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL STRAIN CACO 2; COLON ADENOCARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN DETERMINATION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CELL LINE, TUMOR; COLONIC NEOPLASMS; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; HUMANS; STILBENES; TANNINS;

EID: 66549122506     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. LeCorre L, Fustier P, Chalabi N, Bignon YJ, Bernard-Gallon DJ. Effects of resveratrol on the expression of a panel of genes interacting with the BRCA1 oncosuppressor in human breast cell lines. Clin Chim Acta 2004; 344: 115-121.
2. LeCorre L, Chalabi N, Delort L, Bignon YJ, Bernard-Gallon DJ. Resveratrol and breast cancer chemoprevention: Molecular mechanisms. Mol Nutr Food Res 2005; 49: 462-471.
3. Aziz MH, Kumar R, Ahmad N. Cancer chemoprevention by resveratrol: In vitro and in vivo studies and the underlying mechanisms. Int J Oncol 2003; 23: 17-28.
4. Filip V, Plockova M, Smidrkal J, Spickova Z, Melzoch K, Schmidt S. Resveratrol and its antioxidant and antimicrobial effectiveness. Food Chemistry 2003; 83: 585-593.
5. Wolter F, Akoglu B, Clausnitzer A, Stein J. Down regulation of the cyclin D1/Cdk4 complex occurs during resveratrol-induced cell cycle arrest in colon cancer cell lines. J Nutr 2001; 131: 2197-2203.
6. Delmas D, Rébé C, Lacour S, Filomenko R, Athias A, Gambert P, et al. Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells. J Biol Chem 2003; 278: 41482-41490.
7. Nam S, Smith DM, Dou QP. Tannic acid potently inhibits tumor cell proteasome activity, increases p27 and Bax expression, and induces G1 arrest and apoptosis. Cancer Epidemiol Biomarkers Prev 2001; 10: 1083-1088.
8. Labieniec M, Gabryelak T. Effects of tannins on Chinese hamster cell line B14. Mutat Res 2003; 539: 127-135.
9. Taffetani S, Ueno Y, Meng F, Venter J, Francis H, Glaser S, et al. Tannic acid inhibits cholangiocyte proliferation after bile duct ligation via a cyclic adenosie 5′, 3′-monophosphate-dependent pathway. Am J Pathol 2005; 166: 1671-1679.
10. Labieniec M, Gabryelak T. Oxidatively modified proteins and DNA in digestive gland cells of the fresh-water mussel Unio tumidus in the presence of tannic acid and its derivatives. Mutat Res 2006; 603: 48-55.
11. Chen KS, Hsiao YC, Kuo DY, Chou MC, Chu SC, Hsieh YS, et al. Tannic acid-induced apoptosis and -enhanced sensitivity to arsenic trioxide in human leukemia HL-60 cells. Leuk Res 2009; 33: 297-307.
12. Sakagami H, Satoh K. Prooxidant action of two antioxidants: Ascorbic acid and gallic acid. Prooxidant action of two antioxidants: Ascorbic acid and gallic acid. Anticancer Res 1997; 17: 221-224.
13. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 2002; 8: 893-903.
14. Holian O, Wahid S, Atten MJ, Attar BM. Inhibition of gastric cancer cell proliferation by resveratrol: Role of nitric acid. Am J Physiol Gastrointest Liver Physiol 2002; 282: G809-G816.
15. Cao Y, Wang F, Liu HY, Fu ZD, Han R. Resveratrol induces apoptosis and differentiation in acute promyelocytic leukemia (NB4) cells. J Asian Nat Prod Res 2005; 7: 633-641.
16. Luzi C, Brisdelli F, Cinque B, Cifone G, Bozzi A. Differential sensitivity to resveratrol-induced apoptosis of human chronic myeloid (K562) and acute lymphoblastic (HSB-2) leukemia cells. Biochem Pharmacol 2004; 68: 2019-2030.
17. Pöhland T, Wagner S, Mahyar-Roemer M, Roemer K. Bax and Bak are the critical complementary effectors of colorectal cancer cell apoptosis by chemopreventive resveratrol. Anticancer Drugs 2006; 17: 471-478.
18. Bawadi HA, Bansode RR, Trappey A 2nd, Truax RE, Losso JN. Inhibition of Caco-2 colon, MCF-7 and Hs578T breast, and DU 145 prostatic cancer cell proliferation by water-soluble black bean condensed tannins. Cancer Lett 2005; 218: 153-162.
19. Romero I, Páez A, Ferruelo A, Luján M, Berenguer A. Polyphenols in red wine inhibit the proliferation and induce apoptosis of LNCaP cells. BJU Int 2002; 89: 950-954.
20. Nakagawa H, Kiyozuka Y, Uemura Y, Senzaki H, Shikata N, Hioki K, et al. Resveratrol inhibits human breast cancer cell growth and may mitigate the effect of linoleic acid, a potent breast cancer cell simulator. J Cancer Res Clin Oncol 2001; 127: 258-264.
21. Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N. Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol Cancer Ther 2006; 5: 1335-1341.
22. Shankar S, Singh G, Srivastava RK. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 2007; 12: 4839-4854.
23. Fulda S, Debatin KM. Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol. Cancer Res 2004; 64: 337-346.
24. Delmas D, Rébé C, Micheau O, Athias A, Gambert P, Grazide S, et al. Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells. Oncogene 2004; 23: 8979-8986.
25. Kuo PL, Lin CC. Green tea constituent (-)-epigallocatechin-3-gallate inhibits Hep G2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J Biomed Sci 2003; 10: 219-227.